BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26383589)

  • 21. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
    Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk.
    Becker J; May A; Gerges C; Anders M; Schmidt C; Veits L; Noder T; Mayershofer R; Kreuser N; Manner H; Venerito M; Hofer JH; Lyros O; Ahlbrand CJ; Arras M; Hofer S; Heinrichs SK; Weise K; Hess T; Böhmer AC; Kosiol N; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Ott K; Schmidt T; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
    Cancer Med; 2016 May; 5(5):888-91. PubMed ID: 26783083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.
    Murphy SJ; Hughes AE; Patterson CC; Anderson LA; Watson RG; Johnston BT; Comber H; McGuigan J; Reynolds JV; Murray LJ
    Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.
    Dong J; Gharahkhani P; Chow WH; Gammon MD; Liu G; Caldas C; Wu AH; Ye W; Onstad L; Anderson LA; Bernstein L; Pharoah PD; Risch HA; Corley DA; Fitzgerald RC; ; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Vaughan TL; MacGregor S; Love S; Palles C; Tomlinson I; Gockel I; May A; Gerges C; Anders M; Böhmer AC; Becker J; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Schmidt C; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; Jankowski J; Schumacher J; Neale RE; Whiteman DC; Thrift AP
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2227-2235.e1. PubMed ID: 30716477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
    Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium
    Mol Autism; 2017; 8():21. PubMed ID: 28540026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma.
    Menke V; van Zoest KP; Moons LM; Hansen B; Pot RG; Siersema PD; Kusters JG; Kuipers EJ
    Scand J Gastroenterol; 2012 Apr; 47(4):378-86. PubMed ID: 22243485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.
    Su Z; Gay LJ; Strange A; Palles C; Band G; Whiteman DC; Lescai F; Langford C; Nanji M; Edkins S; van der Winkel A; Levine D; Sasieni P; Bellenguez C; Howarth K; Freeman C; Trudgill N; Tucker AT; Pirinen M; Peppelenbosch MP; van der Laan LJ; Kuipers EJ; Drenth JP; Peters WH; Reynolds JV; Kelleher DP; McManus R; Grabsch H; Prenen H; Bisschops R; Krishnadath K; Siersema PD; van Baal JW; Middleton M; Petty R; Gillies R; Burch N; Bhandari P; Paterson S; Edwards C; Penman I; Vaidya K; Ang Y; Murray I; Patel P; Ye W; Mullins P; Wu AH; Bird NC; Dallal H; Shaheen NJ; Murray LJ; Koss K; Bernstein L; Romero Y; Hardie LJ; Zhang R; Winter H; Corley DA; Panter S; Risch HA; Reid BJ; Sargeant I; Gammon MD; Smart H; Dhar A; McMurtry H; Ali H; Liu G; Casson AG; Chow WH; Rutter M; Tawil A; Morris D; Nwokolo C; Isaacs P; Rodgers C; Ragunath K; MacDonald C; Haigh C; Monk D; Davies G; Wajed S; Johnston D; Gibbons M; Cullen S; Church N; Langley R; Griffin M; Alderson D; Deloukas P; Hunt SE; Gray E; Dronov S; Potter SC; Tashakkori-Ghanbaria A; Anderson M; Brooks C; Blackwell JM; Bramon E; Brown MA; Casas JP; Corvin A; Duncanson A; Markus HS; Mathew CG; Palmer CN; Plomin R; Rautanen A; Sawcer SJ; Trembath RC; Viswanathan AC; Wood N; Trynka G; Wijmenga C; Cazier JB; Atherfold P; Nicholson AM; Gellatly NL; Glancy D; Cooper SC; Cunningham D; Lind T; Hapeshi J; Ferry D; Rathbone B; Brown J; Love S; Attwood S; MacGregor S; Watson P; Sanders S; Ek W; Harrison RF; Moayyedi P; de Caestecker J; Barr H; Stupka E; Vaughan TL; Peltonen L; Spencer CC; Tomlinson I; Donnelly P; Jankowski JA; ;
    Nat Genet; 2012 Oct; 44(10):1131-6. PubMed ID: 22961001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
    Ekiz F; Ormeci N; Coban S; Karabulut HG; Aktas B; Tukun A; Tuncali T; Yüksel O; Alkış N
    Dis Esophagus; 2012 Jul; 25(5):437-41. PubMed ID: 21951971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus.
    Dai JY; Tapsoba Jde D; Buas MF; ; Risch HA; Vaughan TL
    Am J Hum Genet; 2016 Aug; 99(2):352-65. PubMed ID: 27486777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of CD55 from Barrett's esophagus is associated with esophageal adenocarcinoma risk.
    Murao T; Shiotani A; Fujita Y; Yamanaka Y; Kamada T; Manabe N; Hata J; Nishio K; Haruma K
    J Gastroenterol Hepatol; 2016 Jan; 31(1):99-106. PubMed ID: 26202380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.
    Bull LM; White DL; Bray M; Nurgalieva Z; El-Serag HB
    Dis Esophagus; 2009; 22(7):571-87. PubMed ID: 19222528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
    Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
    Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.
    Doecke J; Zhao ZZ; Pandeya N; Sadeghi S; Stark M; Green AC; Hayward NK; Webb PM; Whiteman DC;
    Int J Cancer; 2008 Jul; 123(1):174-80. PubMed ID: 18386788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
    Sun X; Chandar AK; Canto MI; Thota PN; Brock M; Shaheen NJ; Beer DG; Wang JS; Falk GW; Iyer PG; Abrams JA; Venkat-Ramani M; Veigl M; Miron A; Willis J; Patil DT; Nalbantoglu I; Guda K; Markowitz SD; Zhu X; Elston R; Chak A
    PLoS One; 2017; 12(10):e0184962. PubMed ID: 29073141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma.
    Ochs-Balcom HM; Falk G; Grady WM; Kinnard M; Willis J; Elston R; Eng C; Chak A
    Transl Res; 2007 Jul; 150(1):3-17. PubMed ID: 17585859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common variants in FOXP1 are associated with generalized vitiligo.
    Jin Y; Birlea SA; Fain PR; Mailloux CM; Riccardi SL; Gowan K; Holland PJ; Bennett DC; Wallace MR; McCormack WT; Kemp EH; Gawkrodger DJ; Weetman AP; Picardo M; Leone G; Taïeb A; Jouary T; Ezzedine K; van Geel N; Lambert J; Overbeck A; Spritz RA
    Nat Genet; 2010 Jul; 42(7):576-8. PubMed ID: 20526340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.